statistiche ricercatore

BUCCISANO, FRANCESCO

Distribuzione geografica

Continente	#
NA - Nord America	2149
EU - Europa	1500
AS - Asia	324
AF - Africa	60
SA - Sud America	38
OC - Oceania	9
Continente sconosciuto - Info sul continente non disponibili	5
Totale	4085

Salva come PNG Salva come JPEG

Nazione	#
US - Stati Uniti d'America	2116
DE - Germania	943
IT - Italia	190
CN - Cina	133
GB - Regno Unito	100
SE - Svezia	72
IN - India	58
FR - Francia	44
VN - Vietnam	28
ID - Indonesia	26
IE - Irlanda	26
EG - Egitto	24
ZA - Sudafrica	23
CA - Canada	19
RU - Federazione Russa	19
JP - Giappone	18
NL - Olanda	16
CZ - Repubblica Ceca	15
MX - Messico	12
GR - Grecia	11
BR - Brasile	10
CL - Cile	10
DK - Danimarca	10
RO - Romania	9
AU - Australia	8
HK - Hong Kong	7
KR - Corea	7
NO - Norvegia	7
PE - Perù	7
AR - Argentina	6
PK - Pakistan	6
ES - Italia	5
IQ - Iraq	5
PT - Portogallo	5
SA - Arabia Saudita	5
TR - Turchia	5
UA - Ucraina	5
BE - Belgio	4
CH - Svizzera	4
FI - Finlandia	4
IR - Iran	4
PH - Filippine	4
TH - Thailandia	4
AE - Emirati Arabi Uniti	3
AP - ???statistics.table.value.countryCode.AP???	3
CO - Colombia	3
KE - Kenya	3
AT - Austria	2
BY - Bielorussia	2
DZ - Algeria	2
LB - Libano	2
LT - Lituania	2
MA - Marocco	2
PY - Paraguay	2
RS - Serbia	2
SG - Singapore	2
A2 - ???statistics.table.value.countryCode.A2???	1
BG - Bulgaria	1
CR - Costa Rica	1
CY - Cipro	1
ET - Etiopia	1
EU - Europa	1
JO - Giordania	1
KG - Kirghizistan	1
KW - Kuwait	1
KZ - Kazakistan	1
LY - Libia	1
ML - Mali	1
NG - Nigeria	1
PG - Papua Nuova Guinea	1
PL - Polonia	1
SD - Sudan	1
SI - Slovenia	1
SV - El Salvador	1
SY - Repubblica araba siriana	1
TN - Tunisia	1
TW - Taiwan	1
Totale	4085

Salva come PNG Salva come JPEG

Città	#
Woodbridge	381
Houston	265
Fairfield	172
Santa Cruz	102
Ashburn	99
Seattle	98
Wilmington	94
Buffalo	92
Ann Arbor	85
Nürnberg	68
Stockholm	67
Cambridge	58
Rome	50
Guangzhou	33
University Park	31
Beijing	27
Dublin	24
Mountain View	24
Dong Ket	20
Muizenberg	19
Fleming Island	16
San Diego	16
Boardman	15
Chicago	13
Leawood	13
Bengaluru	12
Hangzhou	11
Henderson	11
Milan	11
Phoenix	11
Columbus	10
Los Angeles	10
Cedar Knolls	9
Jakarta	9
Ottawa	9
Atlanta	8
Florence	8
Las Vegas	8
Wuhan	8
Brooklyn	7
Duncan	7
Hudsonville	7
Perugia	7
Riva	7
Shanghai	7
Chengdu	6
Dallas	6
Lake Forest	6
Middletown	6
San Francisco	6
Zhengzhou	6
Birmingham	5
Bologna	5
Chennai	5
Delhi	5
Hanoi	5
Madison	5
Mexico	5
New York	5
Paris	5
Provo	5
Scranton	5
Helsinki	4
Lima	4
London	4
Messina	4
San Jose	4
Tianjin	4
Tokyo	4
Toronto	4
Amsterdam	3
Arvada	3
Beverly	3
Boston	3
Clearwater	3
Denver	3
Farmington	3
Frankfurt am Main	3
Fremont	3
Gurgaon	3
Hartford	3
Jacksonville	3
Jersey City	3
Landshut	3
Manchester	3
Nairobi	3
Nanjing	3
Pescara	3
Roskilde	3
Royneberg	3
Seoul	3
Tübingen	3
Yellow Springs	3
Zurich	3
Aberdare	2
Abu Dhabi	2
Ashland	2
Athens	2
Bacoor	2
Bangkok	2
Totale	2266

Salva come PNG Salva come JPEG

Nome	#
Toward optimization of postremission therapy for residual disease-positive patients with acute myeloid leukemia, file e291c0d4-3ea6-cddb-e053-3a05fe0aa144	903
Idiopathic thrombocytopenic purpura: current concepts in pathophysiology and management., file e291c0d4-3eab-cddb-e053-3a05fe0aa144	496
CD90/Thy-1 is preferentially expressed on blast cells of high risk acute myeloid leukaemias, file e291c0d3-f756-cddb-e053-3a05fe0aa144	459
The revised IPSS predicts survival and leukemic evolution of myelodysplastic syndromes significantly better than IPSS and WPSS: validation by the GROM Italian regional database, file e291c0d4-7e0b-cddb-e053-3a05fe0aa144	398
Treatment of Acute Myeloid Leukemia with 20-30% Bone Marrow Blasts, file e291c0d4-7b99-cddb-e053-3a05fe0aa144	281
Clinical significance of bax/bcl-2 ratio in chronic lymphocytic leukemia, file e291c0d6-4003-cddb-e053-3a05fe0aa144	261
Minimal Residual Disease in Acute Myeloid Leukemia of Adults: Determination, Prognostic Impact and Clinical Applications, file e291c0d6-47b5-cddb-e053-3a05fe0aa144	179
Role of Minimal (Measurable) Residual Disease Assessment in Older Patients with Acute Myeloid Leukemia, file e291c0d7-0fa1-cddb-e053-3a05fe0aa144	168
Technical Aspects of Flow Cytometry-based Measurable Residual Disease Quantification in Acute Myeloid Leukemia: Experience of the European LeukemiaNet MRD Working Party, file e291c0d9-ba2a-cddb-e053-3a05fe0aa144	162
Minimal residual disease detection in pediatric acute myeloid leukemia: does flow cytometry score a point over molecular biology?, file e291c0d4-7e94-cddb-e053-3a05fe0aa144	155
DIAGNOSTIC PERFORMANCE AND SAFETY OF BRONCHOALVEOLAR LAVAGE IN THROMBOCYTOPENIC HAEMATOLOGICAL PATIENTS FOR ASPERGILLOSIS DIAGNOSIS: A MONOCENTRIC, RETROSPECTIVE EXPERIENCE, file e291c0d7-90d4-cddb-e053-3a05fe0aa144	121
Therapeutic Choice in Older Patients with Acute Myeloid Leukemia: A Matter of Fitness, file e291c0d7-9d10-cddb-e053-3a05fe0aa144	111
Applicability and reproducibility of acute myeloid leukaemia stem cell assessment in a multi-centre setting, file e291c0d8-1b26-cddb-e053-3a05fe0aa144	93
Fludarabine, Cytarabine and Gentuzumab Ozogamicin (FLA-GO) as Salvage Therapy and Bridge to Transplant in Adult Relapsed Acute Myeloid Leukemia (AML) Patients, file e291c0d8-1e39-cddb-e053-3a05fe0aa144	70
Phase III, randomized, placebo-controlled trial of CC-486 (oral azacitidine) in patients with lower-risk myelodysplastic syndromes, file e291c0d9-bbed-cddb-e053-3a05fe0aa144	69
MRD in AML: The Role of New Techniques, file e291c0d8-a47c-cddb-e053-3a05fe0aa144	59
Use of Measurable Residual Disease to Evolve Transplant Policy in Acute Myeloid Leukemia: A 20-Year Monocentric Observation, file e291c0d9-2a77-cddb-e053-3a05fe0aa144	58
Second-line administration of thrombopoietin receptor agonists in immune thrombocytopenia: Italian Delphi-based consensus recommendations, file e291c0d9-7cc1-cddb-e053-3a05fe0aa144	54
Longitudinal Evaluation of the QuantiFERON-TB Gold Plus Assay in Hospitalized COVID-19 Patients with a First Indeterminate Result: Resolution of Inflammation and Restoration of T-Lymphocyte Counts and Interferon-Gamma Production, file 3c6f4b71-feb8-4e84-86fc-b8cef6fbdc07	30
In BCR-ABL1 Positive B-Cell Acute Lymphoblastic Leukemia, Steroid Therapy Induces Hypofibrinogenemia, file e291c0d9-bf7a-cddb-e053-3a05fe0aa144	28
Clinical relevance of an objective - limit of detection - limit of quantification - based flow cytometry approach for measurable residual disease assessment in acute myeloid leukemia. A post-hoc analysis of the GIMEMA AML1310 trial, file e291c0d9-7de8-cddb-e053-3a05fe0aa144	27
Case report: A Saprochaete clavata (Magnusiomyces clavatus) severe infection effectively treated with granulocyte transfusion in a young patient with myeloid sarcoma, file 74f64071-7412-47ae-b806-4d24c769eda4	25
FEVER OF UNKNOWN ORIGIN AND MULTIDRUG-RESISTANT ORGANISMS COLONIZATION IN AML PATIENTS, file cac52580-51dc-4cc0-894a-49ae9c34e1ec	13
Direct CD32 T-cell cytotoxicity: implications for breast cancer prognosis and treatment, file ba3f3bba-c1cd-4d5e-85a6-0daf4d622e1c	12
Validation of the T-Lymphocyte Subset Index (TLSI) as a Score to Predict Mortality in Unvaccinated Hospitalized COVID-19 Patients, file 50857deb-e47a-43e4-9c95-91c089143be4	7
Time for Dynamic Assessment of Fitness in Acute Myeloid Leukemia, file 64e70885-5e6c-4708-966b-648171860d4f	7
Predictors of Early Thrombotic Events in Adult Patients with Acute Myeloid Leukemia: A Real-World Experience, file 12096872-3a59-49c9-a096-87c15eb49382	6
Pulmonary function testing for fitness assessment in asymptomatic adults with newly diagnosed acute myeloid leukemia, file f416e02f-ee96-488c-a79d-8ce02895329c	6
Measurable Residual Disease (MRD) as a Surrogate Efficacy-Response Biomarker in AML, file aabf8caf-ff87-4c0c-8774-ac96152f1a53	5
B- and T-Cell Responses After SARS-CoV-2 Vaccination in Patients With Multiple Sclerosis Receiving Disease Modifying Therapies: Immunological Patterns and Clinical Implications, file 4761eef2-f38e-4c2a-8b90-7b254c47a00c	3
Predictors of Early Thrombotic Events in Adult Patients with Acute Myeloid Leukemia: A Real-World Experience, file 47eac2e3-aee8-47a1-8934-17ed6f2c3fa8	2
Pre-transplant persistence of minimal residual disease does not contraindicate allogeneic stem cell transplantation for adult patients with acute myeloid leukemia, file e291c0d6-cd8b-cddb-e053-3a05fe0aa144	2
Venetoclax: Bcl-2 inhibition for the treatment of chronic lymphocytic leukemia, file e291c0d8-1b47-cddb-e053-3a05fe0aa144	2
Myelodysplastic syndromes with del(5q): A real-life study of determinants of long-term outcomes and response to lenalidomide, file dee53335-1e29-4468-ac25-d6de6f925c8f	1
A cluster of Geotrichum clavatum (Saprochaete clavata) infection in haematological patients: a first Italian report and review of literature, file e291c0d6-4000-cddb-e053-3a05fe0aa144	1
GIMEMA AML1310 trial of risk-adapted, MRD-directed therapy for young adults with newly diagnosed acute myeloid leukemia, file e291c0d8-d450-cddb-e053-3a05fe0aa144	1
Eltrombopag versus placebo for low-risk myelodysplastic syndromes with thrombocytopenia (EQoL-MDS): Phase 1 results of a single-blind, randomised, controlled, phase 2 superiority trial, file e291c0d9-01ec-cddb-e053-3a05fe0aa144	1
A new focus on thyrosine kinases inhibitors in eosinophilic granulomatosis with polyangiitis, file e291c0d9-16e6-cddb-e053-3a05fe0aa144	1
Totale	4277

Salva come PNG Salva come JPEG

Categoria	#
all - tutte	5874
article - articoli	0
book - libri	0
conference - conferenze	0
curatela - curatele	0
other - altro	0
patent - brevetti	0
selected - selezionate	0
volume - volumi	0
Totale	5874

Salva come PNG Salva come JPEG

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2017/2018	63	0	0	0	0	0	0	0	0	0	0	31	32
2018/2019	609	58	23	29	30	62	39	49	40	52	62	82	83
2019/2020	655	71	63	56	40	56	54	54	53	70	49	56	33
2020/2021	605	49	72	38	52	59	39	57	42	47	54	46	50
2021/2022	727	39	33	29	69	67	40	65	59	56	65	141	64
2022/2023	727	27	48	116	98	46	70	91	52	63	49	67	0
Totale													4277